Toll-like receptor 9

DB15320Investigational

Toll-like receptor 9 is under investigation in clinical trial NCT03007732 (Pembrolizumab in Combination With Intratumoral SD-101 Therapy).

Mechanism
Curator reviewed
Also known as
CD_ANTIGEN: CD289
Code names
TLR-9

Resolves to

Compound
UNII7GAF379J5J
Targets
Q9NR96TLR9

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Toll-like receptor 9, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In